Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Diarrhea (CID) - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. This report offers a...
-
Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Anemia - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
-
Ottawa, April 28, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global chemotherapy market size was evaluated at USD 9,550 million in 2024 and is expected to be worth around USD 19,870...
-
Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The market for...
-
Austin, TX, USA, March 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Elastomeric Infusions Pumps Market Size, Trends and Insights By Product...
-
Wilmington, Delaware, United States, Transparency Market Research Inc. - , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Pancreatic Cancer Treatment Market is set for remarkable growth, projected to reach...
-
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global non-muscle invasive bladder cancer (NMIBC) market (非筋肉浸潤性膀胱癌市場), valued at US$ 2.6 billion in...
-
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ADCs, or antibody-drug conjugates, are chemotherapeutic agents explicitly designed to treat cancer cells. Antibody-drug conjugates deliver...
-
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Alternative Cancer Treatment Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global alternative...
-
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...